Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
QUESTION: In patients with stable asthma, is the standard chlorofluorocarbon (CFC) containing pressurised metered dose inhaler (PMDI) as effective as other hand held inhaler devices for delivering corticosteroids?
Studies published from 1966 to July 1999 were identified by searching the Cochrane Airways Group trials database and by reviewing bibliographies of relevant studies. Pharmaceutical companies that manufacture inhaled asthma drugs were contacted for further studies.
Studies in any language were selected if they were laboratory, hospital, or community based randomised controlled trials of children or adults with stable asthma that lasted ≥ 4 weeks and compared a single drug delivered by a standard PMDI (with or without a spacer device) with any other hand held inhaler. Trials comparing different doses of the same drug were also included.
2 reviewers independently extracted data on study design, patient characteristics, details of the intervention, study duration, outcomes, and quality. Outcomes included lung function, quality of life measures, symptom scores, drugs for additional relief, acuteexacerbation, days off work or school, treatment failure, patient compliance, patient preference, adverse effects, …
Source of funding: NHS Research and Development Health Technology Assessment Programme.
For correspondence: Dr J Wright, Bradford Hospitals NHS Trust, Bradford Royal Infirmary, Bradford, UK.
A modified version of this abstract appears in ACP Journal Club.